J
Jefferson Health | Einstein Medical Center Philadelphia - Klein Building - Rheumatology Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Fruquintinib
AB-101
Calaspargase Pegol
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
Locations recently updated
High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whethe...
Enrolling
Colorectal Cancer
Drug: Fruquintinib
AB-101 is an off-the shelf, allogeneic cell product made of "natural killer" cells, also called NK cells. White blood cells are part of the immune sy...
Active, not recruiting
Non Hodgkin Lymphoma
Drug: Interleukin-2
Drug: Rituximab
The purpose of this phase 2/3 study is to confirm the recommended doses and to evaluate the safety and pharmacodynamics of Calaspargase pegol for the...
Active, not recruiting
Acute Lymphoblastic Leukemia
Drug: Calaspargase pegol (S95015)
Trial sponsors
A
M
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems